Comparing surgical and conservative treatment of keratinizing squamous metaplasia (leukoplakia) of the bladder: a systematic review
- Authors: Vorobev V.A.1,2, Kosova I.V.3,4, Ibishev K.S.5
-
Affiliations:
- Irkutsk State Medical University
- Bashkir State Medical University
- Russian Medical Academy of Continuous Professional Education
- City Clinical Hospital V.P. Demikhov
- Rostov State Medical University
- Issue: Vol 15, No 4 (2025)
- Pages: 403-416
- Section: Systematic Reviews
- URL: https://bakhtiniada.ru/uroved/article/view/381658
- DOI: https://doi.org/10.17816/uroved693731
- EDN: https://elibrary.ru/LBKFHR
- ID: 381658
Cite item
Abstract
BACKGROUND: Leukoplakia is a condition requiring histological confirmation and is associated with persistent symptoms of recurrent cystitis. No universal treatment standards are currently available.
AIM: This study aimed to compare surgical and conservative treatment approaches for keratinizing squamous metaplasia (leukoplakia) of the bladder in adults.
METHODS: A scientific data search was conducted in MEDLINE/PubMed, Scopus, Web of Science, the Russian Science Citation Index, and other databases (last search: September 2025). Comparative studies and surgical case series following drug therapy failure were included; single case reports, pediatric cases, and schistosomiasis-associated cases were excluded. The primary outcome was clinical and endoscopic resolution, i.e. symptom disappearance and complete epithelialization on follow-up cystoscopy. Secondary outcomes included recurrence, adverse events, cancer occurrence, and quality-of-life measures. Risk of bias was assessed using ROBINS-I and RoB 2.0 tools (ROBINS-I prioritized), and overall certainty of evidence was evaluated using the GRADE approach. A random-effects meta-analysis (DerSimonian–Laird method with Hartung–Knapp adjustment) with heterogeneity assessment (I2, Cochran χ2) was pre-specified but was limited by small sample sizes and substantial heterogeneity.
RESULTS: Seven studies were included (0 randomized controlled trials), comprising a total of 826 patients. Conservative strategies (antibacterial and anti-inflammatory therapy, intravesical instillations) rarely resulted in lesion regression and provided mainly short-term symptom relief. Endoscopic removal or ablation of lesions (laser ablation, argon plasma coagulation, mono- or bipolar transurethral resection) demonstrated high rates of clinical and morphological resolution (80%–97%) and meaningful improvements in quality of life. In the largest series, the 5-year recurrence risk after complete endoscopic removal was 13.9%, with no cases of cancer reported over a median follow-up of 49 months. Laser ablation was associated with fewer coarse scars in the surgical treatment area and greater reduction in pain symptoms compared with transurethral resection; serious complications were rare. Overall certainty of evidence was low to very low (due to retrospective study designs, confounding, and selective reporting), although effect directions were consistent.
CONCLUSION: In symptomatic keratinizing squamous metaplasia of the urothelium, an active management approach is justified, comprising biopsy-based diagnosis verification, elimination of inflammatory triggers, and organ-sparing endoscopic removal of lesions (preferably using laser techniques), followed by scheduled follow-up cystoscopy. Conservative therapy plays an adjunctive role and rarely provides durable resolution. The quality of available evidence remains low to very low, underscoring the need for prospective comparative studies.
About the authors
Vladimir A. Vorobev
Irkutsk State Medical University; Bashkir State Medical University
Author for correspondence.
Email: denecer@yandex.ru
ORCID iD: 0000-0003-3285-5559
SPIN-code: 9896-6243
MD, Dr. Sci. (Medicine)
Russian Federation, Irkutsk; UfaInga V. Kosova
Russian Medical Academy of Continuous Professional Education; City Clinical Hospital V.P. Demikhov
Email: kosovainga@mail.ru
ORCID iD: 0000-0002-0051-0583
MD, Dr. Sci. (Medicine)
Russian Federation, Moscow; MoscowKhalid S. Ibishev
Rostov State Medical University
Email: ibishev22@mail.ru
ORCID iD: 0000-0002-2954-842X
SPIN-code: 9614-0335
MD, Dr. Sci. (Medicine), Professor
Russian Federation, Rostov-on-DonReferences
- Pandey T, Pandey S, Goel A, et al. Leukoplakia of the urinary bladder: keratinising squamous metaplasia. BMJ Case Rep. 2018;2018:bcr2018227019. doi: 10.1136/bcr-2018-227019
- Goncharov ID, Ibishev KHS, Alkhshash AMS, et al. Leukoplakia of the bladder: review of publications from 2018 to 2023. Urologiia. 2024;(2):88–91. doi: 10.18565/urology.2024.2.88-91 EDN: NQPGIE
- Ibishev KHS, Lapteva TO, Todorov SS, et al. Pathomorphological criteria for the differential diagnosis of leukoplakia and chronic recurrent papillomavirus cystitis. Urologiia. 2024;(3):28–32. doi: 10.18565/urology.2024.3.28-32 EDN: AIIFBM
- Khan MS, Thornhill JA, Gaffney E, et al. Keratinising squamous metaplasia of the bladder: natural history and rationalization of management based on review of 54 years experience. Eur Urol. 2002;42(5):469–474. doi: 10.1016/s0302-2838(02)00358-5
- Batura D, Mitsopoulos G. Keratinising cystitis with intestinal metaplasia following a Crohn’s vesico-intestinal fistula. Int Urol Nephrol. 2015;47(5): 803–804. doi: 10.1007/s11255-015-0966-4
- Amin MB, McKenney JK, Paner GP, et al. Icud-eau international consultation on bladder cancer 2012: Pathology. European Urology. 2013;63(1):16–35. doi: 10.1016/j.eururo.2012.09.063
- Yi Z, Ou Z, Guo X, et al. Recurrence factors in patients with Keratinizing squamous metaplasia of the bladder after surgical management: a single-center retrospective study. Transl Androl Urol. 2021;10(2):734–740. doi: 10.21037/tau-20-948 EDN: GWNSRP
- Kulchavenya EV, Brizhatyuk EV. Bladder leukoplakia—is the surgical aggression justified? Urologiia. 2014;(4):21–24. EDN: SVNUDT
- Neimark AI, Ilyinskaya EV, Lebedeva RN, Taranina TS. Diagnosis and treatment of bladder leukoplakia in women. Urologiia. 2009;(2):18–22. EDN: KVQKLL
- Al-Shukri SK, Kuzmin IV, Slesarevskaya MN, Sokolov AV. Choice of treatment tactics for leukoplakia of the bladder in women with chronic cystitis. Urology Reports (St. Petersburg). 2015;5(1):90–91. doi: 10.17816/uroved5190-91 EDN: TRSGXV
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89. doi: 10.1186/s13643-021-01626-4 EDN: LZOATG
- Wang H, Chong T, Tang XY, et al. Transurethral resection in women with symptomatic keratinizing squamous metaplasia of urinary bladder: a retrospective study of 92 cases. Low Urin Tract Symptoms. 2020;12(2):137–142. doi: 10.1111/luts.12294
- Ozbey I, Aksoy Y, Polat O, et al. Squamous metaplasia of the bladder: findings in 14 patients and review of the literature. Int Urol Nephrol. 1999;31(4):457–461. doi: 10.1023/A:1007107110222 EDN: AGHREF
- Slesarevskaya MN, Sokolov AV, Zharkikh AV. Advantages of laser coagulation for bladder leukoplakia. Urology Reports (St. Petersburg). 2012;2(1):16–22. doi: 10.17816/uroved2116-22 EDN: PZTIWF
- Staack A, Schlechte H, Sachs M, et al. Clinical value of vesical leukoplakia and evaluation of the neoplastic risk by mutation analyses of the tumor suppressor gene TP53. Int J Urol. 2006;13(8):1092–1097. doi: 10.1111/j.1442-2042.2006.01503.x
- McKenney JK. Precursor lesions of the urinary bladder. Histopathology. 2019;74(1):68–76. doi: 10.1111/his.13762
- Yakovets EA, Chudnovets IY, Trutnev VP, Yunusov IR. Determination of treatment tactics in patients with chronic cystitis complicated by bladder leukoplakia. Pharmacology & Pharmacotherapy. 2022;(4):34–38. doi: 10.46393/27132129_2022_4_34 EDN: QBRSVU
Supplementary files

